The Tax Inversion Deal Crackdown

The video discusses the pharmaceutical industry's financial landscape, focusing on strategic deals driven by the need for growth and tax benefits. It highlights the challenges posed by US Treasury regulations on mergers and acquisitions, and the reactions of the UK market to these policies. Key companies like AbbVie, Shire, and AstraZeneca are examined in the context of their strategic moves and market responses.

What challenges do companies like AbbVie face with their major drugs like Humira?

Discuss the implications of the recent actions by the Secretary of Treasury on pharmaceutical mergers.